Capsaicin 8% patch repeat treatment in nondiabetic peripheral neuropathic pain: A 52-week, open-label, single-arm, safety study
The Clinical Journal of Pain Sep 29, 2017
Gálvez R, et al. - Authors planned this study to determine the long-term safety and tolerability of capsaicin 8% patch repeat treatment in nondiabetic patients with peripheral neuropathic pain. Generally, the aforementioned treatment over 52 weeks was well tolerated, with variable alteration in sensory function and minimal chance of complete sensory loss.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries